599 Results for "

Allosteric modulator

" in MedChemExpress (MCE) Product Catalog:
Products (599)

599 Results for "Allosteric modulator" in MCE Product Catalog:

25
25 Publications Verification
Cat. No.: HY-100403
CAS No.: 298690-60-5
Purity:  99.67%
Target:  

mGluR

Research Areas:  

Cancer

Ro 67-7476 is a potent positive allosteric modulator of mGluR1 and potentiates glutamate-induced calcium release in HEK293 cells expressing rat mGluR1a with an EC50 of 60.1 nM . Ro 67-7476 is a potent P-ERK1/2 agonist and activates ERK1/2 phosphorylation in the absence of exogenously added glutamate (EC50=163.3 nM) .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-A0106
CAS No.: 14769-73-4
Synonyms: (-)-Tetramisole
Target:  

nAChR Parasite

Levamisole ((-)-Levamisole), an anthelmintic agent with immunomodulatory properties. Levamisole acts as a positive allosteric modulator (PAM) for the α3β2 (EC50=300 μM) and α3β4 (EC50=100 μM) subtype of nAChRs. Orally active .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-17537
CAS No.: 1216665-49-4
Target:  

IRE1

Research Areas:  

Cancer

APY29, an ATP-competitive inhibitor, is an allosteric modulator of IRE1α which inhibits IRE1α autophosphorylation by binding to the ATP-binding pocket with IC50 of 280 nM. APY29 acts as a ligand that allosterically activates IRE1α adjacent RNase domain .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-10167A
CAS No.: 177172-49-5
Purity:  99.66%
Synonyms: R-568 hydrochloride; NPS R-568
Target:  

CaSR

Research Areas:  

Others

Tecalcet Hydrochloride (R 568 Hydrochloride), an orally active calcimimetic compound, allosterically and positively modulates the calcium-sensing receptor (CaSR). Tecalcet Hydrochloride (R 568 Hydrochloride) increases the sensitivity to activation by extracellular Ca 2+ .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P1125
CAS No.: 300851-67-6
Research Areas:  

Others

4-CMTB is a selective free fatty acid receptor 2 (FFA2/GPR43) agonist and a positive allosteric modulator (pEC50=6.38) .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-103320A
CAS No.: 2387505-78-2
Purity:  99.81%
Target:  

CaSR

Research Areas:  

Metabolic Disease

Calhex 231 hydrochloride is a potent negative allosteric modulator that blocks (IC50 = 0.39 μM) increases in [ 3H]inositol phosphates elicited by activating the human wild-type CaSR transiently Ca 2+-sensing receptor. Calhex 231 hydrochloride can be used in the study of traumatic hemorrhagic shock (THS) and diabetic cardiomyopathy (DCM) .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112209
CAS No.: 1451993-15-9
Purity:  99.24%
Target:  

mAChR

Research Areas:  

Neurological Disease

VU0467154 is a positive allosteric modulator of the M4 muscarinic acetylcholine receptor (mAChR), potentiating the response to ACh with pEC50s of 7.75, 6.2 and 6 for rat, human and cynomolgus monkey M4 receptor, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-124634
CAS No.: 2170608-82-7
Purity:  99.68%
Target:  

PANK

Research Areas:  

Neurological Disease

PZ-2891 is an orally bioavailable, brain penetrant pantothenate kinase (PANK) modulator. PZ-2891 act as an orthosteric inhibitor at high concentrations and an allosteric activator at lower sub-saturating concentrations. PZ-2891 inhibits human pantothenate kinases PANK1β, PANK2, and PANK3 with IC50s of 40.2 nM, 0.7 nM and 1.3 nM, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N2370
CAS No.: 30271-38-6
Category:  

Animals Steroids

Target:  

iGluR LXR

24-Hydroxycholesterol is a natural sterol, which serves as a positive allosteric modulator of N-Methyl-d-Aspartate (NMDA) receptorsR, and a potent activator of the transcription factors LXR.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16579
CAS No.: 56776-32-0
Synonyms: HOE 36-801 hydrochloride
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Etifoxine hydrochloride, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine hydrochloride reveals anxiolytic and anticonvulsant properties in rodents .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16579A
CAS No.: 21715-46-8
Synonyms: HOE 36-801
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

Etifoxine, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine reveals anxiolytic and anticonvulsant properties in rodents .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10933
CAS No.: 154235-83-3
Purity:  99.94%
Synonyms: BDP 12
Target:  

iGluR

Research Areas:  

Neurological Disease

CX516 (BDP 12) is an ampakine and acts as an AMPA receptor positive allosteric modulator for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101165
CAS No.: 2259-96-3
Purity:  98.29%
Target:  

iGluR GABA Receptor

Research Areas:  

Neurological Disease

Cyclothiazide is a positive allosteric modulator of ionotropic AMPA-type glutamate receptors. Cyclothiazide inhibits GABAA receptors. Cyclothiazide is frequently used to produce a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current. Cyclothiazide can potentiate responses to kainate in hippocampal neurons. Cyclothiazide has effects on glutamatergic neurotransmission. Cyclothiazide also induces epileptiform EEG activity accompanying behavioral seizures .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-120023
CAS No.: 1432436-13-9
Purity:  99.67%
Target:  

mAChR

Research Areas:  

Neurological Disease

VU0453595 is a highly selective, systemically active M1 positive allosteric modulator (PAM, EC50=2140 nM) for the research of schizophrenia .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-128770
CAS No.: 1638667-79-4
Purity:  98.06%
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

LY3154207 is a potent, subtype selective, and orally available human dopamine D1 receptor positive allosteric modulator (PAM) with minimal allosteric agonist activity (EC50=3 nM) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-124419
CAS No.: 714971-87-6
Purity:  98.42%
Target:  

mGluR

Research Areas:  

Neurological Disease

RO0711401 is a selective and orally active positive allosteric modulator of mGlu1 receptor with an EC50 of 56 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108710
CAS No.: 1809085-30-0
Purity:  99.55%
Target:  

mGluR

Research Areas:  

Neurological Disease

VU0650786 is a potent and selective CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 (mGlu3 NAM), with an IC50 of 392 nM. VU0650786 has antidepressant and anxiolytic activity in rodents .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-109160
CAS No.: 2167246-24-2
Purity:  99.27%
Synonyms: CAD-1883
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and spinocerebellar ataxia (SCA) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-134494
CAS No.: 2375070-79-2
Purity:  99.90%
Target:  

GPR68

Research Areas:  

Neurological Disease

MS48107 is a potent and selective positive allosteric modulator of G protein-coupled receptor 68 (GPR68). MS48107 is selective for GPR68 over the closely related proton GPCRs, neurotransmitter transporters, and hERG ion channels. MS48107 can readily cross the blood-brain barrier (BBB) in mice .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12150
CAS No.: 917837-54-8
Purity:  99.97%
Synonyms: AVL-3288; UCI-4083
Target:  

nAChR

Research Areas:  

Neurological Disease

CCMI (AVL-3288) is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. CCMI has potential in CNS diseases with cognitive dysfunction .
loading...
    loading...